Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 258 for “"Cell-Free-DNA"”.
-
Cell-Free Dna Sequencing In Multiple Myeloma
<p>Multiple myeloma (MM) is an incurable plasma cell dyscrasia. Recent advances in MM therapy, including CAR-T therapy, have increased survival and shown the value of assessing treatment response with great sensitivity, both in acute and long-term settings. Cell-free DNA, DNA fragments which are …
-
MONITORING CANCER USING GENOME-WIDE CELL-FREE DNA FRAGMENTOMES
… Furthermore, the currently available circulating cell-free DNA (cfDNA) assays require deep-targeted sequencing to detect cancer-specific mutations or methylation profiles at low mutant allele frequency (MAF) levels. This study presents a tumor-agnostic approach that is not dependent on mutations. …
-
Detecting cancer from cell-free DNA sequencing fragmentation patterns
Cell-free DNA(cfDNA) represents all non-encapsulated DNA circulating freely in the human circulatory system, which usually exists in the form of wrapping around nucleosomes in the circulating system. Nucleosomes are the basic components of chromatin and play an important role in gene regulation. …
-
The Relationship Between Cell-Free DNA and Resistance Training
… were to explore relationship between cell free DNA (cf-DNA), creatine kinase (CK), C-reactive protein (CRP), vertical jump testing delayed onset muscle soreness (DOMS) in response to a high-volume resistance training protocol, and to assess the sensitivity of cf-DNA to different …
-
Improving diagnosis of tuberculosis from urine cell-free DNA
… samples, such as urine. Transrenal urine cell-free DNA (cfDNA) is a promising biomarker for TB but is challenging to detect because of the short length (<100 bp) and low concentration of TB-specific fragments. We aimed to increase the sensitivity of TB diagnosis from urine cfDNA by …
-
Nucleosomics analysis of cell-free DNA for patient stratification
… in gene regulation and may vary throughout cell differentiation stages and in response to healthy and disease-related processes. In this project I examined different methods of using nucleosome positioning reconstructed from cell-free DNA (cfDNA) as part of a method for patient diagnostics …
-
Cell-Free DNA Fragments as Biomarkers in Radiooncology and Gynecology
Liquid biopsy of cell-free DNA (cfDNA) is a non-invasive diagnostic method that provides valuable biological insights into various diseases by analyzing DNA fragments released into the bloodstream. Despite the increasing availability of cfDNA data and its potential as a biomarker, there is a lack …
-
Cell-free DNA Methylation Signatures in Cancer Detection and Classification
… is rapidly gaining prominence for this purpose. Cell-free DNA (cfDNA) methylation has emerged as a promising biomarker for early cancer detection, tumor type classification, and treatment response monitoring. Currently, most cfDNA methylation profiling technologies are based on bisulfite …
-
Characterization of seminal cell-free DNA in forensic DNA analysis
… information for forensic testing. In forensic DNA analysis, the sperm is the primary focus of testing since it contains and preserves a high concentration of DNA. Components found in the rest of the seminal fluid have been used for biological screening, but there is also a considerable amount …
-
Predicting cancer subtypes from nucleosome profiling of cell-free DNA
… differences between tumors to kill cancer cells using targeted approaches. Typically, this requires a tumor biopsy in order to get tissue for phenotypic and genotypic analysis. However, in late-stage cancer, surgical biopsies of metastases may not be part of the standard of care and …
-
Expanding the accuracy, resolution, and breadth of cell-free DNA investigation
When cells die, they don’t simply vanish without a trace. Instead, they leave behind fingerprints of their genetic and epigenetic identities in the form of cell-free DNA (cfDNA), or the scant amount of highly fragmented DNA circulating in human plasma. As the detritus of apoptotic and necrotic cell …
-
Non-disruptive epigenomic monitoring of cellular states with cell-free DNA
… culture to enhance disease modeling and deliver cell replacement therapies. A prime challenge in developing regenerative therapeutics is achieving a mature cell state, particularly when deriving them from stem cells. Epigenetic changes orchestrate cellular identity determination and accompany …
-
Analysis of cell-free DNA for cancer diagnostics using liquid biopsies
… important for patient diagnostics using cell-free DNA (cfDNA) from body fluids, based on computational analyses of nucleosome occupancy landscapes reconstructed from cfDNA. This thesis establishes the first comprehensive atlas of nucleosome positioning signatures across repetitive …
-
Biological, Clinical, and Functional Implications of Cell-Free DNA Topology in Cancer
Cells can release their DNA into the extracellular space and circulation by active mechanisms or as a product of cell death. In oncology, this cell-free DNA (cfDNA) has emerged as a promising source of cancer biomarkers because it contains actionable information about a patient’s disease and can be …
-
Accurate quantification of placental (fetal) fraction by tissue specific cell-free DNA analysis.
… liquid biopsy analytes such as cell-free DNA (cfDNA) have advanced the field of precision medicine. It is most widely used in noninvasive prenatal testing (NIPT) to screen for untreatable aneuploidies from maternal plasma. An important parameter for the success of the test is …
-
Procoagulant and Anti-Fibrinolytic Properties of Cell-free DNA and Histones in Sepsis
… of the underlying pathophysiology. Recently, cell-free DNA (CFDNA) has emerged as an important link between innate immunity, coagulation, and inflammation. Furthermore, we have previously demonstrated that plasma levels of CFDNA have high discriminative power to predict ICU mortality in …
-
CELL-FREE DNA PROFILING REVEALS MECHANISMS OF ANTI-EGFR DRUG RESISTANCE IN COLORECTAL CANCER
Circulating cell-free DNA (cfDNA) provides a minimally invasive platform for the molecular profiling of cancer. Here, we applied cfDNA to investigate both genetic alterations and inferred transcriptomic profiles in metastatic colorectal cancer (mCRC) patients treated with anti-EGFR antibodies. …
Page 1 of 13